{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Dana-Farber Cancer Institute, Boston, MA, USA",
    "2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA",
    "Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA",
    "1Dana-Farber Cancer Institute, Boston, MA, USA",
    "7Dana-Farber Cancer Institute, Boston, MA, USA",
    "University of Michigan, Ann Arbor, MI, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 8,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Rizwan Romee"
    },
    {
      "affs": [
        1
      ],
      "name": "David Barbie"
    },
    {
      "affs": [
        2
      ],
      "name": "Eden Bobilev"
    },
    {
      "affs": [
        3
      ],
      "name": "Mubin Tarannum"
    },
    {
      "affs": [
        4
      ],
      "name": "Marco Campisi"
    },
    {
      "affs": [
        0
      ],
      "name": "Alan E Bers"
    },
    {
      "affs": [
        0
      ],
      "name": "Ian Gillanders"
    },
    {
      "affs": [
        5
      ],
      "name": "Navin R Mahadevan"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/6kzat0zga5jpz.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0318",
  "fulltext_url": null,
  "id": "6kzat0zga5jpz",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0318",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|CAR-T cell therapy research"
    ]
  ],
  "openalex": "W7225186205",
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-07",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/6kzat0zga5jpz.ris",
  "sources": [
    {
      "first_seen": "2026-11-07T14:21:12Z",
      "native_id": "191ad0e44ddf488e91f783d02de59414",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0318"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|CAR-T cell therapy research",
      "subfield": "oncology"
    }
  ],
  "title": "318 CAR-T and CAR-NK cell combination therapy targeting DLL3 or CD70 surface antigens promotes synergistic antitumor activity in small cell lung cancer",
  "title_text": "318 CAR-T and CAR-NK cell combination therapy targeting DLL3 or CD70 surface antigens promotes synergistic antitumor activity in small cell lung cancer",
  "type": "peer-reviewed",
  "updated_at": "2026-11-09T14:20:59Z",
  "url": "https://research.draconitic.com/paper/6kzat0zga5jpz",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}